Impact of postoperative c-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma

Keiichi Ito, Hidehiko Yoshii, Akinori Sato, Kenji Kuroda, Junichi Asakuma, Akio Horiguchi, Makoto Sumitomo, Tomohiko Asano

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: Preoperative C-reactive protein is a strong predictor of recurrence and prognosis in patients with renal cell carcinoma while postoperative C-reactive protein reportedly predicts survival in patients with metastatic renal cell carcinoma. We evaluated the impact of postoperative C-reactive protein on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma. Materials and Methods: We defined increased preoperative C-reactive protein as 1 mg/dl or greater and postoperative C-reactive protein normalization as at least 1 postoperative measurement of less than 0.3 mg/dl. We reviewed the records of 263 patients with N0M0 clear cell renal cell carcinoma who underwent nephrectomy, and in whom preoperative and postoperative C-reactive protein values were available. We used multivariate analysis to identify independent factors predicting recurrence and prognosis. We also evaluated C-reactive protein at recurrence and its impact on survival. Results: Increased preoperative C-reactive protein and nonnormalization of postoperative C-reactive protein were associated with worse clinicopathological factors. Postoperative C-reactive protein nonnormalization, increased preoperative C-reactive protein, microvascular invasion and histological tumor necrosis were independent predictors for recurrence. Risk stratification using these factors effectively predicted the possibility of recurrence. Anemia, thrombocytosis and postoperative C-reactive protein nonnormalization were independent predictors of overall survival. Postoperative followup revealed recurrence in 50 patients. The 3-year survival rate in patients with C-reactive protein 0.3 mg/dl or greater at recurrence was significantly lower than that in patients with less than 0.3 mg/dl at recurrence (47.3% vs 81.6%). Conclusions: Nonnormalization of postoperative C-reactive protein is a strong predictor of recurrence and prognosis. Patients with C-reactive protein 0.3 mg/dl or greater at recurrence might not survive as long as those with C-reactive protein less than 0.3 mg/dl at recurrence.

Original languageEnglish
Pages (from-to)430-435
Number of pages6
JournalJournal of Urology
Volume186
Issue number2
DOIs
Publication statusPublished - 01-08-2011
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint Dive into the research topics of 'Impact of postoperative c-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma'. Together they form a unique fingerprint.

  • Cite this